Trial Profile
A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy, and Safety Study of Meloxicam SoluMatrix Capsules in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Iroko Pharmaceuticals
- 23 Jun 2016 Results published in an Iroko Pharmaceuticals media release.
- 14 May 2016 Results assessing rescue medication use (N=403) were presented at the 35th Annual Scientific Meeting of the American Pain Society
- 12 May 2016 Results published in the Iroko Pharmaceuticals media release.